USFD Stock Analysis: US Foods Holding | NYSE
Food Distribution | NYSE, USA | Market Cap: 23.283m USD | 12M Return: 50.7% | US9120081099 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 245M
EPS Trend: 99.7%
Qual. Beats: 0
Rev. Trend: 98.9%
Qual. Beats: -1
Warnings
Tailwinds
Seasonality 10.5 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
US Foods Holding Corp. (NYSE: USFD) is a large-cap U.S. foodservice distributor headquartered in Rosemont, Illinois. The company markets, sells, and distributes fresh, frozen, and dry food along with non-food products to a broad range of foodservice customers nationwide, including independent and multi-unit restaurants, regional and national chains, healthcare facilities, hospitality venues, educational institutions, government organizations, and retail locations. In addition to its core distribution business, US Foods offers MOXe, an all-in-one foodservice business application designed to support operators back-office and operational needs. Formerly known as USF Holding Corp., the company was incorporated in 2007, adopted its current name in February 2016, and went public on the NYSE in May 2016.
Operating within the GICS Consumer Staples sector under the Food Distributors sub-industry, US Foods competes in a market traditionally dominated by a small number of large-scale broadline distributors. Food distributors typically generate revenue by purchasing products in bulk from manufacturers and reselling them at modest margins to foodservice operators, with profitability closely tied to logistics efficiency, private-label penetration, and value-added services like digital ordering platforms and business management tools.
- Independent restaurant traffic drives organic volume growth
- Sysco and Performance Food Group competition pressures pricing and margins
- Case-ready and premium protein mix expansion lifts gross margin
| Net Income: 793.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.37 > 1.0 |
| NWC/Revenue: 1.08% < 20% (prev 1.43%; Δ -0.35% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.45b > Net Income 793.0m |
| Net Debt (5.41b) to EBITDA (1.83b): 2.95 < 3 |
| Current Ratio: 1.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (217.7m) vs 12m ago -4.68% < -2% |
| Gross Margin: 17.84% > 18% (prev 17.41%; Δ 0.43% > 0.5%) |
| Asset Turnover: 284.0% > 50% (prev 278.5%; Δ 5.52% > 0%) |
| Interest Coverage Ratio: 4.40 > 6 (EBIT TTM 1.36b / Interest Expense TTM 308.0m) |
| A: 0.03 (Total Current Assets 4.48b - Total Current Liabilities 4.04b) / Total Assets 14.4b |
| B: 0.23 (Retained Earnings 3.29b / Total Assets 14.4b) |
| C: 0.10 (EBIT TTM 1.36b / Avg Total Assets 14.2b) |
| D: 0.43 (Book Value of Equity 4.33b / Total Liabilities 10.0b) |
| Altman-Z'' = 2.04 = BBB |
| DSRI: 1.00 (Receivables 2.52b/2.43b, Revenue 40.3b/39.1b) |
| GMI: 0.98 (GM 17.41% / 17.84%) |
| AQI: 0.99 (AQ_t 0.50 / AQ_t-1 0.50) |
| SGI: 1.03 (Revenue 40.3b / 39.1b) |
| TATA: -0.05 (NI 793.0m - CFO 1.45b) / TA 14.4b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of November 20, 2026, the stock is trading at USD 106.82 with a total of 1,176,231 shares traded. Over the past week, the price has changed by -1.32%, over one month by +6.42%, over three months by -0.65% and over the past year by +50.73%.
Current recommended Stop Loss: 101.80 (which is 4.7% or 1.6 ATR below the current price).
US Foods Holding has received a consensus analysts rating of 4.47. Therefore, it is recommended to buy USFD.
- StrongBuy: 12
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 118.1 | 10.5% |
P/E Trailing = 30.2933
P/E Forward = 19.685
P/S = 0.5771
P/B = 5.3611
P/EG = 1.0535
Revenue TTM = 40.3b USD
EBIT TTM = 1.36b USD
EBITDA TTM = 1.83b USD
Long Term Debt = 4.95b USD (from longTermDebt, last quarter)
Short Term Debt = 152.0m USD (from shortTermDebt, last quarter)
Debt = 5.46b USD (from shortLongTermDebtTotal, last quarter) + Leases 355.0m
Net Debt = 5.41b USD (calculated: Debt 5.46b - CCE 54.0m)
Enterprise Value = 28.7b USD (23.3b + Debt 5.46b - CCE 54.0m)
Interest Coverage Ratio = 4.40 (Ebit TTM 1.36b / Interest Expense TTM 308.0m)
EV/FCF = 27.24x (Enterprise Value 28.7b / FCF TTM 1.05b)
FCF Yield = 3.67% (FCF TTM 1.05b / Enterprise Value 28.7b)
FCF Margin = 2.61% (FCF TTM 1.05b / Revenue TTM 40.3b)
Net Margin = 1.97% (Net Income TTM 793.0m / Revenue TTM 40.3b)
Gross Margin = 17.84% ((Revenue TTM 40.3b - Cost of Revenue TTM 33.1b) / Revenue TTM)
Gross Margin QoQ = 18.30% (prev 18.22%)
Tobins Q-Ratio = 2.00 (Enterprise Value 28.7b / Total Assets 14.4b)
Interest Expense / Debt = 5.64% (Interest Expense 308.0m / Debt 5.46b)
Taxrate = 24.33% (255.0m / 1.05b)
NOPAT = 1.03b (EBIT 1.36b * (1 - 24.33%))
Current Ratio = 1.11 (Total Current Assets 4.48b / Total Current Liabilities 4.04b)
Debt / Equity = 1.26 (Debt 5.46b / totalStockholderEquity, last quarter 4.33b)
Debt / EBITDA = 2.95 (Net Debt 5.41b / EBITDA 1.83b)
Debt / FCF = 5.13 (Net Debt 5.41b / FCF TTM 1.05b)
Total Stockholder Equity = 4.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.58% (Net Income 793.0m / Total Assets 14.4b)
RoE = 18.38% (Net Income TTM 793.0m / Total Stockholder Equity 4.31b)
RoCE = 14.63% (EBIT 1.36b / Capital Employed (Equity 4.31b + L.T.Debt 4.95b))
RoIC = 9.85% (NOPAT 1.03b / Invested Capital 10.4b)
WACC = 6.47% (E(23.3b)/V(28.7b) * Re(6.99%) + D(5.46b)/V(28.7b) * Rd(5.64%) * (1-Tc(0.24)))
Discount Rate = 6.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.36 | Cagr: -5.63%
[DCF] Terminal Value 76.40% ; FCFF base≈1.02b ; Y1≈1.09b ; Y5≈1.31b
[DCF] Fair Price = 68.46 (EV 20.1b - Net Debt 5.41b = Equity 14.7b / Shares 214.7m; r=8.35% [WACC [floored]]; 5y FCF grow 7.67% → 2.50% )
EPS Correlation: 99.69 | EPS CAGR: 21.60% | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.85 | Revenue CAGR: 4.70% | SUE: -2.97 | # QB: -1
EPS current Quarter (2027-03-31): EPS=0.95 | Chg30d=-1.69% | Revisions=-57% | Analysts=10
EPS current Year (2026-12-31): EPS=4.75 | Chg30d=-0.65% | Revisions=-75% | GrowthEPS=+19.3% | GrowthRev=+4.4%
EPS next Year (2027-12-31): EPS=5.52 | Chg30d=-0.41% | Revisions=-46% | GrowthEPS=+16.3% | GrowthRev=+4.0%
[Analyst] Revisions Ratio: -73% (up=2, down=21)